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Abstract By applying the 'recognition mask' strategy to 300 
mammalian sequences containing Notl sites we demonstrated 
that 5' ends of genes are highly enriched in Notl sites. A Notl 
linking clone NL2-252 (D3S1678) containing transferrin recep-
tor (TFRC) gene was used as an initial point for chromosomal 
jumping. One of the jumping clones, J21-045 traverses 210 kbp 
and links NL2-252 to NL26 (D3S1632), a Notl linking clone 
containing highly polymorphic sequences. The TFRC gene was 
mapped to 3q29, close to the telomeric marker D3S2344, by 
linkage analysis, a panel of hybrid cell lines, GeneBridge 4 panel 
and FISH. Clone NLM-007 (D3S4302) was found to contain 
ras-homologous gene RAB7. By FISH and a panel of hybrid cell 
lines this gene was mapped to 3q21. This region is of particular 
interest due to frequent rearrangements in different types of 
leukemia. Clone L2-081 (D3S4283) containing new member of 
ubiquitin-specific proteases (HAUSP gene) was localized in 3p21 
inspiring further investigation of involvement of this gene in 
development of lung and renal carcinomas. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Rare-cutting restriction endonucleases like Notl are very 
useful tools for physical and functional mapping of complex 
genomes. One of the most powerful techniques exploring the 
advantages of rare-cutting enzymes is based on combined ap-
plication of linking and jumping clones [1,2]. In linking clones 
Notl site remains in its natural surroundings as in intact ge-
nome, while in jumping clones left and right flanks of a re-
striction site belong to two different Notl sites neighboring 
each other in the genome. Preparation of genomic libraries 
containing Notl sites has been improved and representative 
Notl linking and jumping libraries have been constructed cov-
ering the whole human genome or the individual chromo-
somes [3,4]. 
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At present, Notl linking clones have become not only im-
portant landmarks in low-resolution physical mapping of the 
human genome but they also highlight the regions of the 
genome where genes are located. Their usefulness in con-
structing Notl restriction maps for the entire chromosomes 
or large chromosomal regions has been demonstrated [1]. 
Their versatility makes them an indispensable tool for join-
ing physical, transcriptional and genetic maps, for ordering 
YAC and cosmid clones into contigs, for locating CpG islands 
and providing DNA fragments for the isolation of regularly 
spaced microsatellite markers [5-7]. 
The Notl linking clones are also good markers for expressed 
genes [8-10]. Random sequencing of the Notl linking and 
jumping clones is suitable to establish their order in the ge-
nome [11]. Here, we demonstrate the effectiveness of the Notl 
linking and jumping libraries in identifying and mapping of 
transcribed sequences in general and in particular for local-
ization of cancer-related genes. 
2. Materials and methods 
2.1. DNA 
DNA isolation, Southern blotting, and other standard procedures 
were performed according to the text-book protocols [12,13]. PFGE 
was done as described earlier [11]. 
2.2. Construction of Notl linking and Notl jumping libraries 
MCH 903.1 is a mouse-human microcell hybrid containing a single 
copy of human chromosome 3, derived from a normal human diploid 
fibroblast cell line HFDC [3], DNA isolated from this cell line was 
used for constructing the following libraries: Notl linking libraries 
NLM and NL2 [3,4] and Notl jumping libraries J21 and J22 [14]. 
Construction of the Notl linking and jumping libraries was described 
elsewhere [4,14]. 
2.3. Primer design and PCR 
PCR primers were designed using the PRIMER program (http:// 
www.bmb.psu.edu/597A/stdnts96/ducker/primer.htm). PCR condi-
tions for amplification of sequences adjacent to the Notl site were 
2.0-3.0 mM MgCl2; 10 mM Tris-HCl, pH 8.8; 50 mM KC1; 0.2 
mM of each dNTP; 100 nM of each primer; 96°C for 5 min, 30-35 
cycles of 96°C for 30 s, annealing at 58°C for 20 s, extension at 72°C 
for 1 min, and final extension at 72°C for 5 min. PCR products were 
analyzed on 1.5-2% agarose gels. Sequences of primers used for PCR 
amplification of TFRC gene: (i) 5' AGGAAGTGACGCACAGCC 3'; 
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(ii) 5' AGGGAGGACACGAGGGTC 3'; of NRL-094: (i) 5' 
ACGTGTCTGTTCAGGTGTGC 3'; (ii) 5' AATTACGGCATTTT-
GACATGC 3'. 
2.4. FISH 
Preparation of metaphase spreads, labeling of probes and hybrid-
ization were essentially the same as described earlier [15]. The R-
banding FISH was based on the known procedures [16]. The slides 
were analyzed with Olympus microscope equipped with a Cohu CCD 
camera and the signals were processed by Cyto Vision Ultra software 
system from Applied Imaging. 
3. Results and discussion 
3.1. NotI sites are mainly located at 5' ends of the genes 
Our work on short-gun sequencing approach to construct 
Noil restriction map of human chromosome 3 led to produc-
tion of more than 300 unique sequences containing NotI sites 
[10]. Using this set of DNA fragments it became possible to 
verify the hypothesis that NotI sites are located mainly at 5' 
ends of the genes [8]. To achieve this aim, we have used a 
'recognition mask' strategy [17,18]. This procedure allowed us 
to analyze the oligonucleotide composition of a selected se-
quence or set of sequences. The degree of similarity (F) of the 
given set of sequences may be evaluated by comparison of 
oligonucleotide frequency distribution of F for new set with 
the distribution for the 'training' set (5) and for the random 
set. If the frequency distribution for the given set of sequences 
overlaps with the pattern for one of the training sets or with 
the pattern for random sequences, it indicates, respectively, 
the similarity or dissimilarity of the analyzed and the training 
sequences. 
Approximately 300 NotI site-flanking sequences with an 
average length of about 250-500 bp were compared with 
two training sets containing 2100 5'-flanking and 2400 3'-
flanking regions (300 bp for each sequence) of human genes 
from the EMBL database (Release 30). EMBL accession 
numbers of Notl-ftanks were from Z22238 to Z22509 and 
from X87544 to X87575. 
Comparisons were made with oligonucleotides shorter than 
octamers. The same procedure for comparison of the Notl-
flanking sequences with the 5'- and the 3'-regions demon-
strated a profoundly different pattern: NotI sequences differ 
from the 3'-flanking regions as the random sequences do (Fig. 
Fig. 1. Comparison of the oligonucleotide compositions for two sets of sequences estimated by the distributions of F values. For each sequence 
of each set the measure of similarity F is calculated. The height of the column indicates the number of sequences of one set with the same F. 
All heights are normalized to have the equal maximum values for each set. A: Distribution of the 3'-flanking regions, random and NotI se-
quences drawn using 3'-flanking regions as a training set. The F values of the JVbil-flanks are remote from the F values of the 3'-flanking se-
quences. B: Distribution of the 5'-flanking regions, random and NotI sequences drawn using 5'-flanking regions as a training set. The histo-
gram of the TVoil-flanks is very similar to the histogram of the 5'-flanks. 
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1A). Distribution mean values for the Notl-ftanks, 3'-flanks 
and random sequences are 0.6, 0.9 and 0.65, respectively. The 
degree of overlapping for the Notl- and 3'-flanks is as low as 
5%. At the same time there is a non-random correlation be-
tween oligo compositions of Notl sequences and 5'-flanking 
regions (Fig. IB). The mean values of frequency distribution 
are 0.82, 0.98 and 0.65 for the JVoil-flanks, 5'-flanks and rand-
om sequences, respectively. Most of the Notl-ftanks possess 
the same degree of similarity with the recognizing mask as the 
5'-flanks themselves. The difference between the Notl-ftanks 
and 3'-flanks was even greater than the difference between the 
latter and the random sequences. It implies that at a high level 
of significance the Notl sites were virtually never located at 
the 3'-flanks of the genes. On the other hand, there is a high 
level of coincidence of the Notl sites and the 5'-flanks of 
human genes. Taken this pattern into account would simplify 
searching the homology between known sequences and newly 
sequenced Noil-flanks. Our conclusion is consistent with the 
observation that Notl clones containing portions of the genes, 
revealed identities to the 5' ends of the genes [10,15]. 
Interestingly, several genes, which might be important for 
the carcinogenesis, were identified by Notl linking clones. Hu-
man melanoma NCK protein gene (NL2-270), human amino-
acylase ACY gene (NL1-245), human arginine-rich ARP gene 
(NL1-216) and others were localized previously [10,15] and 
here we present additional data on use of Notl linking clones 
for identification and mapping of genes important for growth 
and differentiation control. 
3.2. Localization of the TFRC gene 
The NL2-252 clone sequence (EMBL accession number 
Z22395), a 237 bp segment, was completely identical to the 
5' part of the TFRC gene [10,19]. This gene has been shown 
previously to be important for growth/differentiation and 
probably is involved in the development of leukemia [20,21]. 
Due to the absence of informative polymorphic markers in the 
vicinity of the TFRC gene, it had not been precisely localized 
on the genetic map of the chromosome 3 [22,23]. For this 
reason, we decided to map this gene more precisely. 
Both BamRl-Notl halves of the insert from the NL2-252 
clone (D3S1678) were used as probes to isolate the corre-
sponding Notl jumping clones from the J21 and J22 libraries 
(Fig. 2A). One jumping clone, named J21-045, covered about 
210 kb as detected by PFGE (Fig. 2B). Using the 0.6 kbp 
BamHl-Notl fragment from the J21-045 clone as a probe, 
the overlapping Notl linking clone NL26 (D3S1632) was iden-
tified. The 14 kb BamHl-Notl fragment of this clone was used 
to identify another overlapping jumping clone J21-055 (Fig. 
2A). Using these two clones we have established a Notl re-
striction map near TFRC gene encompassing about 0.5 mbp 
(Fig. 2A, B). Clones NL2-252 and NL26 were mapped by 
FISH (Fig. 2C) and using the panel of hybrid cell lines [24] 
to 3q29. All DNAs from the NL26 contig were sequenced 
around Notl sites, the average sequence length was about 
1000 bp [11]. Search of the GENBANK database using 
Fig. 2. Mapping of the 3q29 region with linking and jumping 
clones. A: Schematic map of NL26 contig. Orientation of the contig 
towards telomere is unknown. B: PFGE analysis of NL26 contig. 
B.A, B.B: Hybridization with PFGE filter no. 1 and no. 2 respec-
tively. Human DNA was digested with Notl. Hybridizations were 
performed with: 1, NL2-252, 4.5 kb Notl-BamHI fragment; 2, 
NL26, 0.6 kb Notl-BamHI fragment; 3, NL26, 14 kb Notl-BamHI 
fragment; 4, J21-055, 0.55 kb Notl-BamHI fragment. C: Chromoso-
mal localization of NL26 DNA by FISH; positive signals are shown 
by arrows (3q29). 
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Fig. 3. Taql polymorphism of NL26 DNA. Lanes 1-10: Human ge-
nomic DNA isolated from various individuals and digested with 
Taql. Two polymorphic alíeles used for linkage analysis are marked 
on the left side. Size markers are indicated on the right side. 
BLAST program [25] revealed no significant sequence similar-
ity for clones NL26 and J21-055 with any sequence in the 
databank. The Notl linking clone NL26 exhibited restriction 
fragment length polymorphism (RFLP, Fig. 3). A RFLP de-
tected by Taql restriction endonuclease was used to localize 
NL26 DNA by linkage mapping. The two alíeles of 6.5 and 
6 kbp have a frequency of heterozygotes of 0.48. Human 
genomic DNA samples for the reference families were pro-
vided by CEPH. The procedures for genotyping and linkage 
analysis were performed as described earlier [26]. The two-
point linkage analysis was performed on a VAX/VMS main-
frame computer using the CRI-MAP linkage program. Gen-
otype data for the reference markers were obtained from the 
CEPH database 6. Two-point linkage data indicated 10; 10 
and 9 cm genetic distances from the most telomeric D3S1311 
(lod: 3.5), D3S1265 (lod: 5.04) and D3S42 (lod: 17.06) 
markers respectively. Multipoint linkage analysis failed to po-
sition NL26 DNA uniquely (lods > 3) on the reference map 
[27]. 
To localize the TFRC gene precisely, we generated PCR 
primers specifically for this gene (near NL2-252, see Section 
2). CEPH mega Y AC pools A and B (Research Genetics) were 
screened and only one positive YAC clone was identified, 
827c9. However, this YAC clone appeared to be useless due 
to its chimeric nature. 
We mapped NRL-094 (D3S3870) about 1 mbp telomeric to 
NL2-252 (our unpublished data), to the very telomeric region 
of human chromosome 3, 4.8 cR from D3S3954 (WI-9695) 
and 1.6 cR from D3S2344 using radiation hybrid panel Gene-
Bridge 4 (Research Genetics). 
In summary, our results demonstrated that the TFRC gene 
is located close to the D3S2344 marker, telomeric to the 
D3S3669 and D3S1601 markers, and centromeric to the 
D3S1311 marker. 
3.3. Localization of the RAB7 gene 
FASTA analysis of sequences from another Notl linking 
clone, NLM-007 (D3S4302, EMBL Z22474) revealed that 
this clone contained sequences virtually identical (97.4% 
over 151 bp) to the 5' end of human ras-homologous gene 
RAB7 [28]. 
The non-identity was due to two mismatches and two dele-
tions. All of them were located in GC-rich regions where most 
of the sequence errors occur due to compression of the bands 
during electrophoresis. Therefore we assume that these four 
non-identities were caused by sequencing errors either in the 
initial RAB7 sequence, or in NLM-007 DNA, or in both 
fragments. 
RAB7 protein belongs to a superfamily of small molecular 
weight GTPases known to be associated with early and late 
endosomes [29]. The RAB7 function is not required for early 
internalization events, but is crucial in downstream degrada-
tive events [28]. Chromosomal localization of the RAB7 gene 
could be important for various reasons. However, mapping of 
genes which possess many structurally homologous members 
becomes a difficult task if cDNA clones are applied. Our Notl 
linking clones contain in average about 8 kb insert that should 
be sufficient for mapping. Notl fragment of NLM-007 clone 
(about 6 kb) was applied for mapping using panel of hybrid 
cell lines [24] and FISH. The results from both types of experi-
ments were in good agreement and mapped NLM-007 to 
3q21. 
It should be noticed that this region is especially interesting 
due to its frequent involvement in different types of leukemia 
and myelodisplastic syndrome [30,31]. The 3q21-q26 rear-
rangements include translocations, inversions, deletions, and 
duplications. No genes important for the development of leu-
kemia have been identified in this locus so far. The potential 
importance of RAB7 gene in development of these malignan-
cies should be examined in future. 
3.4. Localization of new ubiquitin-specific protease gene in 3p21 
Clone L2-081 (D3S4283, EMBL Z94768) displayed 90.4% 
identity over 197 bp to recently discovered new ubiquitin-spe-
cific protease gene HAUSP [32]. Considering the accuracy of 
our sequences [10,11] we can be confident that these matches 
mean that L2-081 contain 5' end of the HAUSP gene. 
HAUSP gene codes for a cellular 135 kDa protein. The func-
tion of this protein is presently unknown but it was shown 
that it binds herpes simplex virus type 1 (HSV1) immediate 
early protein VmwllO. This binding stimulates expression of 
viral genes [32]. We have localized this gene in 3p21 region. 
This region has been regarded as the tentative site for at 
least one or probably more tumor suppressor genes (TSG) due 
to the frequent occurrence of deletions in tumors. Many stud-
ies have shown abnormalities of the short arm of chromosome 
3 in kidney, lung, breast, ovary, cervix, testis and nasophar-
yngeal carcinomas giving reason to focus on 3p in the search 
for a candidate TSG or group of them [33]. 
It was also shown that 3p21 is a breakpoint in myelodis-
plastic syndrome and acute myeloid leukemia [34]. The ubiq-
uitin-dependent proteolysis plays a role in diverse cellular 
processes, including cell cycle control, DNA repair, stress re-
sponse and selective protein degradation [35,36]. Alteration in 
ubiquitin pathway may result in cancer and different members 
of this pathway could have oncogene or TSG activity [37,38]. 
Indeed, it was found that TRE oncogene is a member of 
ubiquitin-specific proteases [39] and expression of ubiquitin-
activating enzyme El (UBEL1) is greatly reduced in almost all 
lung tumor cell lines [35]. Since UBEL1 was localized in 3p21 
it was suggested as candidate TSG but no prove for this 
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function was presented so far. Since we mapped the H A U S P 
gene also in 3p21 it raises the question if this gene itself or in 
cooperation with UBEL1 plays a role in development of lung, 
renal and other solid tumors and inspire further investiga-
tions. 
In conclusion, in these experiments we have demonstrated 
the usefulness of NotI linking clones for localization of genes 
probably involved in growth/differentiation control in normal 
and malignant cells. Obviously, using the similar strategies, 
the same approach might be easily extended to Notl linking 
and jumping libraries specific for other chromosomes. 
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